DIN 02435411 — SIMBRINZA 0.2 %; 1 %
SIMBRINZA is a suspension of Brinzolamide / Brimonidine marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Brinzolamide / Brimonidine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02435411
- Brand name
- SIMBRINZA
- Active ingredient
- Brinzolamide / Brimonidine
- Strength
- 0.2 %; 1 %
- Dosage form
- SUSPENSION
- Route
- OPHTHALMIC
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Topical carbonic anhydrase inhibitor / alpha-2 adrenergic agonist combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.